Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
PLoS One ; 15(4): e0232009, 2020.
Article in English | MEDLINE | ID: mdl-32353018

ABSTRACT

Non-melanoma skin cancer (NMSC) has a high and increasing incidence all over the world. Solar radiation is the main aetiology for humans. Although most research into photocarcinogenesis uses UVB as a source of radiation, UVA is also carcinogenic in long term. Pomegranate (PGE) and cocoa (CE) extracts have been used for medicinal purposes for time immemorial. Recently, it has been claimed that some of their properties may be an effective preventative measure against photocarcinogenesis and photoaging, but to date in vivo models have not been tested using RUVA, the objective of the present work. A lower incidence of lesions was observed in SKH-1 mice treated with PGE (p<0.001), and lower incidence of invasive squamous carcinoma in both treatment groups (p<0.001 for PGE and p<0.05 for CE); the PGE group also showed a lower level of cell proliferation than the control group (p<0.001). Significantly greater p53 alteration was observed in the control group than the treatment groups (p<0.001 for PGE and p = 0.05 for CE). No significant differences were found in relation to TIMP-1 and MMP-9. Taken together, the results suggest that oral feeding of PGE and CE to SKH-1 mice affords substantial protection against the adverse effects of RUVA, especially PGE.


Subject(s)
Chemoprevention/methods , Neoplasms, Radiation-Induced/prevention & control , Plant Extracts/pharmacology , Animals , Anticarcinogenic Agents/pharmacology , Cacao/drug effects , Disease Models, Animal , Female , Mice , Mice, Hairless , Neoplasms, Radiation-Induced/pathology , Pomegranate/drug effects , Skin/pathology , Skin Neoplasms/pathology , Ultraviolet Rays/adverse effects
2.
Med. oral patol. oral cir. bucal (Internet) ; 25(2): e195-e204, mar. 2020. tab
Article in English | IBECS | ID: ibc-196249

ABSTRACT

BACKGROUND: The main objective of this study was to estimate the prevalence of human papillomavirus-DNA (HPV-DNA) in the saliva of sexually active women with HPV-related cervical intraepithelial neoplasias (CIN) and compare the findings with a healthy control group. The secondary objectives were: 1) to determine the concordance between genital and oral HPV types in sexually active women with HPV-related CIN; 2) to analyze whether sexual habits influence the presence of HPV-related CIN; 3) to determine whether sexual habits influence the presence of oral HPV. MATERIAL AND METHODS: Saliva samples were collected from 100 sexually active women, 50 with HPV-related CIN and 50 healthy subjects presenting normal cytology. PCR assay was used to detect HPV-DNA. RESULTS: The prevalence of oral HPV infection in saliva samples was 14% in women with HPV-related CIN, while in the healthy group it was 12%, without statistically significant difference (p = 0.766). As for the concordance between genital and oral HPV types in women with HPV-related CIN, concordance was only observed for HPV-16, whereby among 22 women with genital HPV-16, only one (4.54%) also presented oral HPV-16. Regarding the possible influence of sexual habits on the presence of cervical pathology and presence of oral HPV, it was found that marital status, age at first intercourse, number of lifetime sexual partners, and condom use are related with the presence of cervical pathology (p < 0.001; p = 0.017; p = 0.002; and p < 0.001, respectively); condom use was also found to be related to the presence of oral HPV (p < 0.001). CONCLUSIONS: The prevalence of HPV-DNA in the saliva of sexually active women with HPV-related CIN is similar to healthy women. The concordance between genital and oral HPV types is low. Both the presence of cervical pathology and the presence of oral HPV are related to sexual habits. Wider sample size is required to confirm this results


No disponible


Subject(s)
Humans , Female , Young Adult , Adult , Papillomaviridae/isolation & purification , Saliva/virology , 31574/virology , Uterine Cervical Neoplasms/virology , Case-Control Studies , 31574/epidemiology , Uterine Cervical Neoplasms/epidemiology , Prevalence , Polymerase Chain Reaction , Risk Factors , DNA, Viral , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...